{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:09:34Z","timestamp":1778821774503,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["TCO-125272"],"award-info":[{"award-number":["TCO-125272"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002879","name":"Canadian Institutes of Health Research Canadian HIV Trials Network","doi-asserted-by":"publisher","award":["CTN 273"],"award-info":[{"award-number":["CTN 273"]}],"id":[{"id":"10.13039\/501100002879","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.sapharm.2026.03.009","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:04:22Z","timestamp":1775181862000},"page":"775-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The influence of frailty on co-medication network structures and anticholinergic burden in people living with HIV"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-0650","authenticated-orcid":false,"given":"Henry Ukachukwu","family":"Michael","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Jos\u00e9e","family":"Brouillette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robyn","family":"Tamblyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley K.","family":"Fellows","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.sapharm.2026.03.009_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40266-013-0093-9","article-title":"The next therapeutic challenge in HIV: polypharmacy","volume":"30","author":"Edelman","year":"2013","journal-title":"Drugs Aging"},{"issue":"7","key":"10.1016\/j.sapharm.2026.03.009_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40266-023-01037-1","article-title":"Polypharmacy and aging in people living with HIV: 6 years of experience in a multidisciplinary outpatient clinic","volume":"40","author":"Cattaneo","year":"2023","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sapharm.2026.03.009_bib5","first-page":"CD015196","article-title":"Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia","volume":"8","author":"Taylor-Rowan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.sapharm.2026.03.009_bib6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/ageing\/afaa090","article-title":"Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis","volume":"49","author":"Pieper","year":"2020","journal-title":"Age Ageing"},{"issue":"13","key":"10.1016\/j.sapharm.2026.03.009_bib7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/QAD.0000000000003966","article-title":"Cognitive impact of anticholinergic and sedative burden in people with HIV","volume":"38","author":"Michael","year":"2024","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.sapharm.2026.03.009_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029221","article-title":"Analysis of anticholinergic and sedative medicine effects on physical function, cognitive function, appetite and frailty: a cross-sectional study in Australia","volume":"9","author":"Lim","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.sapharm.2026.03.009_bib9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/QAD.0000000000003806","article-title":"The association between anticholinergic\/sedative burden and physical frailty in people aging with HIV","volume":"38","author":"Michael","year":"2024","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.sapharm.2026.03.009_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40801-021-00256-5","article-title":"Associations between anticholinergic medication exposure and adverse health outcomes in older people with frailty: a systematic review and meta-analysis","volume":"8","author":"Mehdizadeh","year":"2021","journal-title":"Drugs - real world outcomes"},{"issue":"3","key":"10.1016\/j.sapharm.2026.03.009_bib11","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"10.1016\/j.sapharm.2026.03.009_bib12","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/jgs.14101","article-title":"Systematic review of prevalence and predictors of frailty in individuals with human immunodeficiency virus","volume":"64","author":"Levett","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.sapharm.2026.03.009_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/gerona\/glr118","article-title":"Drug metabolism in older people\u2014A key consideration in achieving optimal outcomes with medicines","volume":"67A","author":"McLachlan","year":"2012","journal-title":"Journals Gerontol Ser A"},{"issue":"4","key":"10.1016\/j.sapharm.2026.03.009_bib14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/ageing\/afab003","article-title":"New Horizons in the impact of frailty on pharmacokinetics: latest developments","volume":"50","author":"Hilmer","year":"2021","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.sapharm.2026.03.009_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1517\/14740338.2016.1165664","article-title":"Anticholinergics: theoretical and clinical overview","volume":"15","author":"Nishtala","year":"2016","journal-title":"Expet Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/pan\/mpq037","article-title":"Inferential network analysis with exponential random graph models","volume":"19","author":"Cranmer","year":"2011","journal-title":"Polit Anal"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yebeh.2013.03.030","article-title":"Network analysis reveals patterns of antiepileptic drug use in children with medically intractable epilepsy","volume":"28","author":"Ibrahim","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.sapharm.2026.03.009_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phrs.2016.12.018","article-title":"Polypharmacy in older adults: Association rule and frequent-set analysis to evaluate concomitant medication use","volume":"116","author":"Held","year":"2017","journal-title":"Pharmacol Res"},{"issue":"10","key":"10.1016\/j.sapharm.2026.03.009_bib19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/pds.4432","article-title":"Association rules method and big data: evaluating frequent medication combinations associated with fractures in older adults","volume":"27","author":"Nishtala","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.sapharm.2026.03.009_bib20","series-title":"Inferential Methods in Social Network Analysis","author":"Yang","year":"2017"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s44222-023-00139-0","article-title":"Approaching disease transmission with network science","volume":"2","author":"Vishnempet Shridhar","year":"2024","journal-title":"Nat Rev Bioeng"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s41109-024-00670-y","article-title":"Estimating the impact of physician risky-prescribing on the network structure underlying physician shared-patient relationships","volume":"9","author":"Ran","year":"2024","journal-title":"Appl Netw Sci"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12913-024-11005-z","article-title":"Social network analysis for medical narcotics in South Korea: focusing on patients and healthcare organizations","volume":"24","author":"Kim","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.sapharm.2026.03.009_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jad.2019.02.062","article-title":"Exploring comorbidity between anxiety and depression among migrant Filipino domestic workers: a network approach","volume":"250","author":"Garabiles","year":"2019","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.sapharm.2026.03.009_bib25","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1007\/s11357-023-00987-z","article-title":"A network-based approach to explore comorbidity patterns among community-dwelling older adults living alone","volume":"46","author":"Lee","year":"2024","journal-title":"GeroScience"},{"issue":"2","key":"10.1016\/j.sapharm.2026.03.009_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/pds.3384","article-title":"Network analysis of drug prescriptions","volume":"22","author":"Cavallo","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.sapharm.2026.03.009_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18094859","article-title":"A network approach for the study of drug prescriptions: analysis of administrative records from a local health unit (ASL TO4, regione piemonte, Italy)","volume":"18","author":"Miglio","year":"2021","journal-title":"Int J Environ Res Publ Health"},{"issue":"12","key":"10.1016\/j.sapharm.2026.03.009_bib28","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.sapharm.2021.06.021","article-title":"An introduction to network analysis for studies of medication use","volume":"17","author":"Askar","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2026.03.009_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/rej.2014.1628","article-title":"The drug prescription network: a system-level view of drug Co-Prescription in community-dwelling elderly people","volume":"18","author":"Bazzoni","year":"2014","journal-title":"Rejuvenation Res"},{"issue":"5","key":"10.1016\/j.sapharm.2026.03.009_bib30","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1109\/JBHI.2019.2939028","article-title":"Network analysis and visualisation of opioid prescribing data","volume":"24","author":"Hu","year":"2020","journal-title":"IEEE J Biomed Health Inform"},{"key":"10.1016\/j.sapharm.2026.03.009_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1211491","article-title":"Revealing the dynamic landscape of drug-drug interactions through network analysis","volume":"14","author":"Jeong","year":"2023","journal-title":"Front Pharmacol"},{"issue":"19","key":"10.1016\/j.sapharm.2026.03.009_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10194486","article-title":"A network analysis of drug combinations associated with acute Generalized exanthematous pustulosis (AGEP)","volume":"10","author":"Martinez-De la Torre","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.sapharm.2026.03.009_bib33","series-title":"Exponential Random Graph Models for Social Networks: Theory, Methods, and Applications. Structural Analysis in the Social Sciences","first-page":"9","article-title":"What are exponential random graph models?","author":"Robins","year":"2012"},{"key":"10.1016\/j.sapharm.2026.03.009_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12883-016-0527-1","article-title":"Understanding and optimizing brain health in HIV now: protocol for a longitudinal cohort study with multiple randomized controlled trials","volume":"16","author":"Mayo","year":"2016","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11136-019-02291-w","article-title":"Relationships between cognition, function, and quality of life among HIV+ Canadian men","volume":"29","author":"Mayo","year":"2020","journal-title":"Qual Life Res"},{"issue":"3","key":"10.1016\/j.sapharm.2026.03.009_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"issue":"SUPPL. 1","key":"10.1016\/j.sapharm.2026.03.009_bib37","first-page":"S142","article-title":"The 2012 update to the anticholinergic cognitive burden scale","volume":"61","author":"Campbell","year":"2013","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib38","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1038\/s41598-020-65989-9","article-title":"Anticholinergic burden in children, adults and older adults in Slovenia: a nationwide database study","volume":"10","author":"Cebron","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAI.0000000000001755","article-title":"Cognitive burden of common non-antiretroviral medications in HIV-Infected women","volume":"79","author":"Rubin","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"10.1016\/j.sapharm.2026.03.009_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/QAD.0000000000002768","article-title":"Effects of anticholinergic medication use on brain integrity in persons living with HIV and persons without HIV","volume":"35","author":"Cooley","year":"2021","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.sapharm.2026.03.009_bib41","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/hiv.13236","article-title":"Factors partitioning physical frailty in people aging with HIV: a classification and regression tree approach","volume":"23","author":"Inceer","year":"2022","journal-title":"HIV Med"},{"issue":"5","key":"10.1016\/j.sapharm.2026.03.009_bib42","article-title":"Disentangling the effects of comorbidity and polypharmacy on cognitive function and physical frailty in individuals with HIV","volume":"97","author":"Michael","year":"2024","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.sapharm.2026.03.009_bib43","series-title":"Systems Biology Modelling and Analysis","first-page":"363","article-title":"Network modelling methods for precision medicine","author":"Nushi","year":"2022"},{"key":"10.1016\/j.sapharm.2026.03.009_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s40294-016-0015-x","article-title":"Introduction to the modeling and analysis of complex systems: a review","volume":"4","author":"Niazi","year":"2016","journal-title":"Complex Adapt Syst Model"},{"issue":"2","key":"10.1016\/j.sapharm.2026.03.009_bib45","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevE.67.026126","article-title":"Mixing patterns in networks","volume":"67","author":"Newman","year":"2003","journal-title":"Phys Rev E"},{"issue":"1","key":"10.1016\/j.sapharm.2026.03.009_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1108\/OIR-03-2018-0093","article-title":"Social media analytics: analysis and visualisation of news diffusion using NodeXL","volume":"43","author":"Ahmed","year":"2019","journal-title":"Online Inf Rev"},{"key":"10.1016\/j.sapharm.2026.03.009_bib47","series-title":"Improved Circular Layouts BT - Graph Drawing","first-page":"386","author":"Gansner","year":"2007"},{"issue":"4 SE-Original Research","key":"10.1016\/j.sapharm.2026.03.009_bib48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.5770\/cgj.22.387","article-title":"An emerging concern\u2014high rates of frailty among middle-aged and older individuals living with HIV","volume":"22","author":"McMillan","year":"2019","journal-title":"Can Geriatr J"},{"issue":"7","key":"10.1016\/j.sapharm.2026.03.009_bib49","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/bcp.13590","article-title":"The relationship between frailty and polypharmacy in older people: a systematic review","volume":"84","author":"Guti\u00e9rrez-Valencia","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.sapharm.2026.03.009_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40266-022-00952-z","article-title":"Frailty and potentially inappropriate prescribing in older people with polypharmacy: a Bi-Directional relationship?","volume":"39","author":"Randles","year":"2022","journal-title":"Drugs Aging"},{"key":"10.1016\/j.sapharm.2026.03.009_bib51","doi-asserted-by":"crossref","unstructured":"Jamieson H, Nishtala PS, Bergler HU, et al. Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial. Lipsitz LA, ed. Journals Gerontol Ser A. Published online January 24, 2023. doi:10.1093\/gerona\/glac249.","DOI":"10.1093\/gerona\/glac249"},{"issue":"8","key":"10.1016\/j.sapharm.2026.03.009_bib52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archinte.167.8.781","article-title":"A drug burden index to define the functional burden of medications in older people","volume":"167","author":"Hilmer","year":"2007","journal-title":"Arch Intern Med"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112600080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155174112600080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:26:41Z","timestamp":1778819201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155174112600080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S155174112600080X"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.03.009","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The influence of frailty on co-medication network structures and anticholinergic burden in people living with HIV","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2026.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}